Related Experiment Video
Updated: May 8, 2026
14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters
Giuseppina Maccarrone1, Claudia Ditzen, Alexander Yassouridis
1Max Planck Institute of Psychiatry, Kraepelinstr. 2, D-80804 Munich, Germany.
Journal of Psychiatric Research
|August 22, 2013
Summary
Researchers identified unique protein biosignatures in cerebrospinal fluid for major depression, bipolar disorder, and schizophrenia. These molecular signatures achieved over 90% accuracy in classifying patients, aiding psychiatric disorder diagnosis and stratification.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Psychiatric disorders stem from disrupted molecular pathways impacting brain circuits.
- Understanding disease-specific molecular alterations is crucial for etiology and diagnostics.
Purpose of the Study:
- To identify disease-specific protein biosignatures in cerebrospinal fluid (CSF) for major depression, bipolar disorder, and schizophrenia.
- To evaluate the utility of these biosignatures for patient stratification and diagnostic purposes.
Main Methods:
- Utilized Reverse Phase Protein Microarray technology to analyze CSF protein expression.
- Compared protein patterns in depressed (n=36), bipolar (n=27), and schizophrenic (n=35) patients against healthy controls (n=35).
Main Results:
- Disease-specific protein biosignatures were identified, achieving >90% accuracy in stratifying patient groups.
- Proteins involved in neuronal growth (NEGR1, NPDC1), neurotransmission (SEZ6), and oxidative damage protection (GPX3) distinguished patients from healthy individuals, suggesting molecular overlap.
Conclusions:
- This study represents a foundational step towards a molecular biosignature-based psychiatric patient stratification system.
- Identified protein signatures show potential as biomarkers for clinical trials, aiding diagnosis, subgroup stratification, and treatment response monitoring.
Keywords:
BiosignaturesCerebrospinal fluidMultiplex analysisProtein clustersProtein levelsPsychiatric patient group stratification
